Pfizer – Talk Bio

Pfizer, Geron Downsize to Streamline Costs

1 week ago talkbio0Tagged commercial strategy, cost-cutting, Geron, Pfizer, Rytelo, Staff, Switzerland

Pfizer layoffs Switzerland; Geron layoffs one-third staff; cost-cutting; restructuring plan; Rytelo commercial strategy; Pfizer cost realignment; biopharma layoffs 2025

Pfizer’s Tukysa Shows Strong PFS Benefit in First-Line HER2+ Breast Cancer Maintenance at SABCS 2025, Sparking Debate with Enhertu

1 week ago talkbio0Tagged Enhertu, first-line maintenance, HER2-positive carcinoma of breast, HER2CLIMB-05, Pfizer, Progression-Free Survival, SABCS, Tukysa

Tukysa; Pfizer; HER2-positive breast cancer; SABCS 2025; HER2CLIMB-05; progression-free survival; Enhertu; first-line maintenance

FDA Broadens COVID-19 Vaccine Safety Probe to Adults Under New Health Leadership

1 week ago talkbio0Tagged Adult, COVID19 (disease), Moderna, Myocarditis, Pfizer, public trust, safety review, United States Food and Drug Administration, vaccine deaths, Vaccines

FDA; COVID-19 vaccines; safety review; adults; Robert F. Kennedy Jr.; vaccine deaths; public trust; Pfizer; Moderna; myocarditis

Pfizer Reduces Stake in BioNTech; Candel Pauses Pancreatic Cancer Program

1 month ago talkbio0Tagged Acquisition, BioNTech, Comirnaty, expansion, Metsera, mRNA Vaccine, Pancreatic carcinoma, Pfizer, pipeline

Pfizer; BioNTech; stake reduction; Candel Therapeutics; pancreatic cancer; Comirnaty; mRNA vaccine; Metsera acquisition; pipeline expansion

Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama

1 month ago talkbio0Tagged Acquisition, bidding war, CVR, Glucagon-Like Peptide 1, Metsera, Nordisk, Obesity, Pfizer, regulatory certainty

Pfizer; Metsera; acquisition; Novo Nordisk; bidding war; obesity drugs; GLP-1; CVR; regulatory certainty

Pfizer Triumphs Over Novo Nordisk with $10B Bid to Acquire Metsera

1 month ago talkbio0Tagged Acquisition, Approved, bidding war, Drug Industry, Glucagon-Like Peptide 1, Metsera, Nordisk, Obesity, Pfizer, shareholder

Pfizer; Novo Nordisk; Metsera; obesity drugs; GLP-1; acquisition; bidding war; shareholder approval; pharmaceutical industry

Novo Nordisk Ups the Stakes With $10B Bid for Metsera, Surpassing Pfizer’s Offer

1 month ago talkbio0Tagged antitrust litigation, bidding war, contingent value right, Drug Industry, Metsera, Novo Nordisk, Pfizer

Novo Nordisk; Pfizer; Metsera; bidding war; acquisition; $10 billion; contingent value right; pharmaceutical industry; antitrust litigation

Delaware Court Denies Pfizer’s Bid to Block Novo Nordisk-Metsera Deal

1 month ago talkbio0Tagged Antitrust, Delaware Court, merger agreement, Metsera, Nordisk, Obesity, Pfizer, restraining order, Transitory, United States Federal Trade Commission

Delaware Court; Pfizer; Novo Nordisk; Metsera; temporary restraining order; merger agreement; antitrust; FTC; obesity drugs

Metsera Bidding War Grips Obesity Drug Field as Novo Nordisk and Pfizer Escalate Offers

1 month ago talkbio0Tagged Acquisition, Antitrust, bidding war, Disputes, Dominance, Glucagon-Like Peptide 1, Legal, Market, Metsera, Novo Nordisk, Obesity, Pfizer

Metsera; obesity drugs; bidding war; Novo Nordisk; Pfizer; acquisition; GLP-1; antitrust; market dominance; legal disputes

Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama

1 month ago talkbio0Tagged Acquisition, analysts, Antitrust, Buyout, CEO Mike, lawsuit, Metsera, Novo Nordisk, Obesity, Pfizer

Novo Nordisk; Metsera; acquisition; Pfizer; buyout; obesity drugs; analysts; lawsuit; antitrust; CEO Mike Doustdar